#regulatoryscience search results
【Regulatory Science Activity Report has now been published】 We have compiled the FY2024 achievements of #PMDA #RegulatoryScience activities into this report. It details various activities, including research introductions by paper authors and epidemiological studies using…
Proud to join th÷ FDA–#AACR #Oncology Educational Fellowship, a fully online program connecting early-career researchers with FDA experts. Grateful to learn about oncology drug development, regulatory science, and evidence evaluation through May 2026! #RegulatoryScience
We are excited to welcome the 2025–2026 FDA–AACR Oncology Educational Fellows. These 20 early-career researchers will explore the intersection of cancer research, drug development, and the regulatory review process in collaboration with @FDAOncology. brnw.ch/21wXr5Y
The regulatory journey starts after your document is done. From EMA Policy 0070 to Health Canada’s PRCI, writing with these in mind is essential. 🎥 Join us Oct 23, 11 AM EST. Register now: ow.ly/6miQ50Xf9XT #ClinicalTrials #RegulatoryScience
📊 FDA's OCE has published game-changing pooled analyses of clinical trial data. Now YOU can propose the next research question through Project Collaborate. Selected ideas become collaborative studies with comprehensive datasets. shareyourvoice.ideascalegov.com/c/shareyourvoi… #RegulatoryScience
📢 The 3rd Malaysia-Japan Symposium (31 Jul 2025) featured updates on NPRA/MHLW/PMDA, and insights on RWD, RMP, CTs & ATLAS presented by Dr. Terada from NCC. A vital step for global collaboration & patient access. #RegulatoryScience #ATLAS #NCC #Cancer #Oncology #ClinicalResearch
🚨 Big shift in #Biosimilars: Experts argue clinical efficacy studies may no longer be needed, paving the way for “biogenerics.” Could this cut costs & speed access for patients? Read more here: hubs.ly/Q03JPc3z0 #Healthcare #RegulatoryScience #Pharma
Get certified at #BMES2025 🏆 Join the webinar (Sept 10) + workshop (Oct 10) to earn your Regulatory Science for BME Certificate 🔗 hubs.la/Q03HG0wd0 #BiomedicalEngineering #RegulatoryScience
🔬 Reflecting on a decade of progress! FDA Oncology Center of Excellence presents the 10th annual workshop on patient outcomes in cancer trials. Oct 8, virtual. Don't miss insights on future PRO data analysis. #OncologyResearch #RegulatoryScience fda.gov/news-events/fd…
What’s the Airlock Initiative? Discover how it fosters collaboration among industry, academia, and regulators to tackle challenges in healthcare innovation. 🌍💡 #HealthcareInnovation #RegulatoryScience #UKCEiRSI 🎬 Full recording: youtube.com/watch?v=4CbTym…
100 regulators & scientists gathered in Paris to advance animal-free testing 🇫🇷 nanoPASS showcased digital twins for inflammation prediction. Big step toward replacing animal tests. #AnimalFreeTesting #nanoPASSeu #RegulatoryScience @JSI_SLO shorturl.at/fODYE
Smarter, faster drug development starts with AI-enhanced MIDD. Learn how Certara is advancing PBPK, QSP, and regulatory strategy with AI. 📺 Watch our on-demand CHI webinar: certara.com/on-demand-webi… #DrugDevelopment #MIDD #RegulatoryScience
Excited to share that I’ll be speaking at #ASH2024 on 12/9/24. My talk, titled “From Detection to Development: A Regulatory Perspective on MRD” will explore #MRD in addition to discussing recent efforts on development of MRD as a novel endpoint. #RegulatoryScience #FDA
📢 @FDAOncology is crowdsourcing research questions for Project Collaborate from the broader cancer community Submit your ❓s by September 26! ascopost.com/news/september… #CancerResearch #RegulatoryScience
The EMA has officially qualified Certara’s Simcyp Simulator — the first and only PBPK platform to earn this milestone. A breakthrough in regulatory trust for mechanistic modeling. 📅 Oct 14 | ⏱️ 11am ET 🔗 Register: ow.ly/BMIz50X85Bq #Simcyp #PBPK #RegulatoryScience
🚨Last chance to register for our PQRS symposium next week! We have an exciting panel of speakers lined up to discuss effective, science-led & risk-based decision making. Register your interest in attending here: rb.gy/yeo47f #RegulatoryScience #PharmaTech
Tomorrow: join us & @Boehringer for @GalienFdn's Week of Innovation! Learn about our 2025 Prix Galien nominee which is enabling faster decisions and democratizing access to therapies worldwide. Register now: hubs.ly/Q03Q2x030 #PrixGalienUSA #RegulatoryScience
Happening in one hour: join us, @Boehringer & our fellow nominees for @GalienFdn's Week of Innovation. Learn how we're streamlining regulatory review so therapies can be accessed by patients faster. Register Now: hubs.ly/Q03Qlxcw0 #PrixGalienUSA #RegulatoryScience
👥 The panel talks are wrapping up at #iDR25—soon we’ll reunite from individual tracks for the final plenary! It’s inspiring to see global leaders from #PatientAdvocacy, R&D, funding, #RegulatoryScience & industry under one roof, working together to advance #DrugRepurposing.
Proud to join th÷ FDA–#AACR #Oncology Educational Fellowship, a fully online program connecting early-career researchers with FDA experts. Grateful to learn about oncology drug development, regulatory science, and evidence evaluation through May 2026! #RegulatoryScience
We are excited to welcome the 2025–2026 FDA–AACR Oncology Educational Fellows. These 20 early-career researchers will explore the intersection of cancer research, drug development, and the regulatory review process in collaboration with @FDAOncology. brnw.ch/21wXr5Y
A day of expert exchange and collaboration to advance sustainable access to biosimilar therapies across Latin America. #BiosimilarsLatAm2025 #Biosimilars #RegulatoryScience #Biopharma #Nearshoring #PharmaIndustry #LatAm #Mexico2025
Regulatory science is shaping the future of contamination control. Learn how evidence-based policies are helping life-science manufacturers balance safety, innovation, and compliance. Read more: emmainternational.com #RegulatoryScience #ContaminationControl #LifeSciences
When your data meets the EMA or FDA, every variable matters. That’s why we design assays with 'method validation in mind' from the first pipette to the final curve. #RegulatoryScience #Diagnostics #ELISA #IVD
【Regulatory Science Activity Report has now been published】 We have compiled the FY2024 achievements of #PMDA #RegulatoryScience activities into this report. It details various activities, including research introductions by paper authors and epidemiological studies using…
【Regulatory Science Activity Report has now been published】 We have compiled the FY2024 achievements of #PMDA #RegulatoryScience activities into this report. It details various activities, including research introductions by paper authors and epidemiological studies using…
Regulatory science is shaping the future of contamination control. Learn how evidence-based policies are helping life-science manufacturers balance safety, innovation, and compliance. Read more: emmainternational.com #RegulatoryScience #ContaminationControl #LifeSciences
📊 FDA's OCE has published game-changing pooled analyses of clinical trial data. Now YOU can propose the next research question through Project Collaborate. Selected ideas become collaborative studies with comprehensive datasets. shareyourvoice.ideascalegov.com/c/shareyourvoi… #RegulatoryScience
🔬 Reflecting on a decade of progress! FDA Oncology Center of Excellence presents the 10th annual workshop on patient outcomes in cancer trials. Oct 8, virtual. Don't miss insights on future PRO data analysis. #OncologyResearch #RegulatoryScience fda.gov/news-events/fd…
Get certified at #BMES2025 🏆 Join the webinar (Sept 10) + workshop (Oct 10) to earn your Regulatory Science for BME Certificate 🔗 hubs.la/Q03HG0wd0 #BiomedicalEngineering #RegulatoryScience
100 regulators & scientists gathered in Paris to advance animal-free testing 🇫🇷 nanoPASS showcased digital twins for inflammation prediction. Big step toward replacing animal tests. #AnimalFreeTesting #nanoPASSeu #RegulatoryScience @JSI_SLO shorturl.at/fODYE
Applications for Apr 13, 2023 #FDA_ASCOFellowsDay Workshop are open now! asco.smapply.org/prog/AprilFell…. Hybrid format: FDA campus & online. Learn about #ClinicalTrials #RegulatoryScience #DrugDevelopment & #drugapproval! @ASCO #OCEProjectSocrates
Excited to share that I’ll be speaking at #ASH2024 on 12/9/24. My talk, titled “From Detection to Development: A Regulatory Perspective on MRD” will explore #MRD in addition to discussing recent efforts on development of MRD as a novel endpoint. #RegulatoryScience #FDA
📢 The 3rd Malaysia-Japan Symposium (31 Jul 2025) featured updates on NPRA/MHLW/PMDA, and insights on RWD, RMP, CTs & ATLAS presented by Dr. Terada from NCC. A vital step for global collaboration & patient access. #RegulatoryScience #ATLAS #NCC #Cancer #Oncology #ClinicalResearch
[Speaker Intro] 🎤 Workshop : The Q-Submission Program & Software as a Medical Device Speaker: Dr. Yu Zhao Affiliation: Bridging Consulting, USA 📌 Full Forum’s program: pharmacy.mahidol.ac.th/dhp2024/progra… #เภสัชมหิดล #คณะเภสัชศาสตร์ #RegulatoryScience #RegulatoryAffairs #MUPY
Great #RegulatoryScience event on #AI & #toxicology! Big thanks to Drs. Tong (FDA), Greene (Recursion) & Martin (Pfizer) Excellent showing of trainee's science with 23 posters! Travel award winners are: Postdocs: G. Wyatt & D. Tsai Students: H. Roe, K. Dinh, E. Farkas, D. Teri 👍
🚨 Big shift in #Biosimilars: Experts argue clinical efficacy studies may no longer be needed, paving the way for “biogenerics.” Could this cut costs & speed access for patients? Read more here: hubs.ly/Q03JPc3z0 #Healthcare #RegulatoryScience #Pharma
2024 #RegulatoryScience Symposium by @tamutox is focused on "Innovating Drug Safety Evaluation with Artificial Intelligence: Where Does Toxicology Fit?" August 21, 2:30-5:30 PM (US Central) in VENI 107B or live stream (register for a link) tx.ag/RegScience2024 @NIEHS @fdacder
👥 The panel talks are wrapping up at #iDR25—soon we’ll reunite from individual tracks for the final plenary! It’s inspiring to see global leaders from #PatientAdvocacy, R&D, funding, #RegulatoryScience & industry under one roof, working together to advance #DrugRepurposing.
Application Deadline is 11:59 pm tonight for the Apr 13, 2023 #FDA_ASCOFellowsDay Workshop! asco.smapply.org/prog/AprilFell…. Hybrid format: FDA campus & online. Learn about #ClinicalTrials #RegulatoryScience #DrugDevelopment & #drugapproval! @ASCO #OCEProjectSocrates
🌐 The 13th Global Summit on Regulatory Science is starting today! Join us as we gather with international partners to explore the theme of "Emerging Technologies for Food and Drug Safety" 🍽️💊 🖥️ Tune in live at europa.eu/!Gck8fh #GSRS2023 #RegulatoryScience #FoodSafety
Join us Tuesday, Dec. 5, 4-5 p.m. to learn about our MS in Regulatory Science program. The virtual information session will include a brief overview of the program, the application process, and time for questions. bit.ly/RegSciDec5 #RegulatoryScience #GraduateSchool
📢 @FDAOncology is crowdsourcing research questions for Project Collaborate from the broader cancer community Submit your ❓s by September 26! ascopost.com/news/september… #CancerResearch #RegulatoryScience
MHRA showcasing healthcare innovation💡 Last week, the MHRA showcased the Centres of Excellence for Regulatory Science and Innovation, driving advancements in Healthcare 🔬 More 👇 nationalhealthexecutive.com/articles/mhra-… @MHRAgovuk #RegulatoryScience #Innovation #AI #MedTech #Pharmacogenomics…
Something went wrong.
Something went wrong.
United States Trends
- 1. Blue Origin 7,788 posts
- 2. Megyn Kelly 30K posts
- 3. New Glenn 8,714 posts
- 4. Vine 33.7K posts
- 5. Senator Fetterman 18.5K posts
- 6. CarPlay 4,367 posts
- 7. Brainiac 5,485 posts
- 8. #NXXT_JPMorgan N/A
- 9. World Cup 101K posts
- 10. Portugal 62.3K posts
- 11. Matt Gaetz 14K posts
- 12. GeForce Season 1,057 posts
- 13. Padres 28.6K posts
- 14. Eric Swalwell 26K posts
- 15. Black Mirror 5,197 posts
- 16. Katie Couric 9,720 posts
- 17. Man of Tomorrow 6,042 posts
- 18. Osimhen 100K posts
- 19. Grade 1 26.2K posts
- 20. Cynthia 112K posts